AdvaMed elects Edwards CEO Mussallem as chair of board

TriMed Staff | | Cardiovascular Business | Cardiac Imaging
Michael A. Mussallem, chairman and CEO of Edwards Lifesciences, was elected to a two-year term as chairman of the board of directors of the Advanced Medical Technology Association (AdvaMed). 

For the past two years, he has served as chairman of AdvaMed's board committee on Payment and Healthcare Delivery, according to the Irvine, Calif.-based Edwards.

Mussallem has headed Edwards since it was spun-off from Baxter International and began operating as an independent company in April 2000, the company said.  Prior to that, he was responsible for the worldwide operations of both Baxter's CardioVascular business and its Biopharmaceuticals business, Edwards reported.

TriMed Staff

Related Content

Cardiologists work to standardize the diagnosis and management of acute myocarditis
New AI program delivers rapid, accurate echo video assessments
Cardiologists to highlight the many benefits of AI-powered CCTA evaluations
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage
Cleerly’s momentum continues as AI specialists raise $106M
Philips, Mayo Clinic using AI to improve cardiac MRI technology

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.